Get a glimpse into our company and investor data—powered by the PitchBook Platform
Oral analgesic tablets for chronic pain in adults. The drug is an oral analgesic indicated for the management of moderate to severe chronic pain in adults when a continuous, around-the-clock opioid analgesic is needed for an extended period of time.
Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
---|
This information is reserved for PitchBook Platform users. To explore Janssen Pharmaceuticals (Nucynta franchise)‘s full profile, request access.
Request full access to PitchBookInvestor Name | Investor Type | Holding | Participating Rounds | Investor Since | Board Seat | Contact Info |
---|
This information is reserved for PitchBook Platform users. To explore Janssen Pharmaceuticals (Nucynta franchise)‘s full profile, request access.
Request full access to PitchBook